Skip to main content

26.07.2019 | Original Paper

Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Eosinophils are seen in a number of dermatologic conditions. While the extent of their function in these diseases remains to be fully elucidated, pathogenic activity in bullous pemphigoid suggests a more significant role than previously thought. Several dermatoses have a fairly characteristic histologic morphology of eosinophil infiltration. We hypothesized that epidermal expression of eotaxins and TSLP would differ by disease, perhaps explaining the different histologic morphologies. We performed a retrospective study of eosinophil rich dermatoses to perform immunohistochemistry. We collected 49 specimens composed of bullous pemphigoid (n = 15), atopic dermatitis (n = 12), drug rash (n = 8), arthropod assault (n = 5), and non-bullous pemphigoid eosinophilic spongiosis (n = 5). We used lichen planus (n = 4) as a control for lymphocyte-mediated inflammation. TSLP was diffusely expressed in all epidermal samples, whereas eotaxins demonstrated a weaker staining. Eotaxins and TSLP demonstrated a gradient between basal and spinous keratinocytes. The correlation between overall basal keratinocyte and spinous keratinocyte staining of eotaxins and TSLP with the number of eosinophils demonstrated a significant correlation between eotaxin-1 (R = 0.404, P = 0.004), eotaxin-2 (R = 0.576, P < 0.001), and eotaxin-3 (R = 0.512, P < 0.001), but not TSLP (R = 0.164, P = 0.251). These remained significant after correcting for multiple comparisons. While we were unable to detect significant differences in epidermal expression of eotaxins and TSLP in various eosinophil rich dermatoses, we identified a significant correlation of spinous keratinocyte eotaxin staining with tissue eosinophilia. Our identification of a correlation of spinous keratinocyte eotaxin staining with tissue eosinophilia may provide insight into local eosinophil chemotaxis.
Literatur
6.
Zurück zum Zitat Cianferoni A, Spergel J (2014) The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol 10:1463–1474CrossRef Cianferoni A, Spergel J (2014) The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol 10:1463–1474CrossRef
8.
Zurück zum Zitat Frezzolini A, Teofoli P, Cianchini G et al (2002) Increased expression of eotaxin and its specific receptor CCR8 in bullous pemphigoid. Eur J Dermatol 12:27–31PubMed Frezzolini A, Teofoli P, Cianchini G et al (2002) Increased expression of eotaxin and its specific receptor CCR8 in bullous pemphigoid. Eur J Dermatol 12:27–31PubMed
10.
Zurück zum Zitat Günther C, Wozel G, Dressler J et al (2004) Tissue eosinophilia in pemphigoid gestationis: association with eotaxin and upregulated activation markers on transmigrated eosinophils. Am J Reprod Immunol 51:32–39CrossRef Günther C, Wozel G, Dressler J et al (2004) Tissue eosinophilia in pemphigoid gestationis: association with eotaxin and upregulated activation markers on transmigrated eosinophils. Am J Reprod Immunol 51:32–39CrossRef
13.
Zurück zum Zitat Liu LY, Jarjour NN, Busse WW, Kelly EA (2003) Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J Allergy Clin Immunol 112:556–562CrossRef Liu LY, Jarjour NN, Busse WW, Kelly EA (2003) Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J Allergy Clin Immunol 112:556–562CrossRef
14.
Zurück zum Zitat Long H, Zhang G, Wang L, Lu Q (2016) Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 50:189–213CrossRef Long H, Zhang G, Wang L, Lu Q (2016) Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 50:189–213CrossRef
20.
Zurück zum Zitat Shinkai A, Yoshisue H, Koike M et al (1999) A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163:1602–1610PubMed Shinkai A, Yoshisue H, Koike M et al (1999) A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163:1602–1610PubMed
21.
Zurück zum Zitat Shrikhande M, Hunziker T, Braathen LR et al (2000) Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol 80:277–280CrossRef Shrikhande M, Hunziker T, Braathen LR et al (2000) Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol 80:277–280CrossRef
23.
Zurück zum Zitat Wakugawa M, Nakamura K, Hino H et al (2000) Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 143:112–116CrossRef Wakugawa M, Nakamura K, Hino H et al (2000) Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia. Br J Dermatol 143:112–116CrossRef
27.
Zurück zum Zitat Ying S, Meng Q, Zeibecoglou K et al (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C–C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163:6321–6329PubMed Ying S, Meng Q, Zeibecoglou K et al (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C–C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163:6321–6329PubMed
Metadaten
Titel
Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses
Publikationsdatum
26.07.2019
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2019
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-019-01954-5

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.